Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Life Enhancer is a multi-strain probiotic supplement investigated for its potential therapeutic benefits in gastrointestinal disorders. In clinical research conducted at institutions such as Renji Hospital affiliated with Shanghai Jiaotong University School of Medicine, the product has been evaluated for the treatment of post-cholecystectomy diarrhea (PCD). The formulation typically consists of a blend of beneficial bacterial strains designed to modulate the gut microbiota, improve intestinal barrier function, and alleviate symptoms of dysbiosis following gallbladder removal. As a probiotic, its mechanism involves competitive inhibition of pathogenic bacteria, production of short-chain fatty acids, and regulation of local immune responses in the gut.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Life Enhancer.